37 related articles for article (PubMed ID: 17275636)
1. Warfarin cessation is non-essential in patients undergoing total knee arthroplasty--a case-control study.
Phillips A; Dan M; Schaefer N; Randle R
J Orthop Surg Res; 2015 Jan; 10():16. PubMed ID: 25627822
[TBL] [Abstract][Full Text] [Related]
2. Guiding warfarin self-management in children: development of a warfarin nomogram.
Jones S; Hislop J; Allan A; Kuzmitsky A; Pham-Crepps M; Greenway A; Monagle P; Newall F
Res Pract Thromb Haemost; 2023 Nov; 7(8):102255. PubMed ID: 38193059
[TBL] [Abstract][Full Text] [Related]
3. Implications of an inpatient warfarin dosing nomogram on safety outcomes post-discharge.
Chamoun N; Macías CG; Donovan JL; Klugman R; Gore J; Salameh P; Tran MT
J Thromb Thrombolysis; 2017 May; 43(4):454-462. PubMed ID: 27981490
[TBL] [Abstract][Full Text] [Related]
4. Use of signals and systems engineering to improve the safety of warfarin initiation.
Hyun G; Li J; Bass AR; Mohapatra A; Woller SC; Lin H; Eby C; McMillin GA; Gage BF
J Thromb Thrombolysis; 2016 Nov; 42(4):529-33. PubMed ID: 27443162
[TBL] [Abstract][Full Text] [Related]
5. The use of warfarin for DVT prophylaxis following hip and knee arthroplasty: how often are patients within their target INR range?
Nam D; Sadhu A; Hirsh J; Keeney JA; Nunley RM; Barrack RL
J Arthroplasty; 2015 Feb; 30(2):315-9. PubMed ID: 25261182
[TBL] [Abstract][Full Text] [Related]
6. Predictors for moderate to severe acute postoperative pain after total hip and knee replacement.
Liu SS; Buvanendran A; Rathmell JP; Sawhney M; Bae JJ; Moric M; Perros S; Pope AJ; Poultsides L; Della Valle CJ; Shin NS; McCartney CJ; Ma Y; Shah M; Wood MJ; Manion SC; Sculco TP
Int Orthop; 2012 Nov; 36(11):2261-7. PubMed ID: 22842653
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery.
Turpie AG; Schmidt AC; Kreutz R; Lassen MR; Jamal W; Mantovani L; Haas S
Vasc Health Risk Manag; 2012; 8():363-70. PubMed ID: 22701330
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for elective hip and knee arthroplasty: a multimodal thromboprophylaxis protocol.
Vulcano E; Gesell M; Esposito A; Ma Y; Memtsoudis SG; Gonzalez Della Valle A
Int Orthop; 2012 Oct; 36(10):1995-2002. PubMed ID: 22684546
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Holbrook A; Schulman S; Witt DM; Vandvik PO; Fish J; Kovacs MJ; Svensson PJ; Veenstra DL; Crowther M; Guyatt GH
Chest; 2012 Feb; 141(2 Suppl):e152S-e184S. PubMed ID: 22315259
[TBL] [Abstract][Full Text] [Related]
10. Quality measures and benchmarking for warfarin therapy.
Witt DM
J Thromb Thrombolysis; 2011 Apr; 31(3):242-8. PubMed ID: 21327505
[TBL] [Abstract][Full Text] [Related]
11. High incidence of complications from enoxaparin treatment after arthroplasty.
Neviaser AS; Chang C; Lyman S; Della Valle AG; Haas SB
Clin Orthop Relat Res; 2010 Jan; 468(1):115-9. PubMed ID: 19669848
[TBL] [Abstract][Full Text] [Related]
12. VKORC1 variant genotypes influence warfarin response in patients undergoing total joint arthroplasty: a pilot study.
González Della Valle A; Khakharia S; Glueck CJ; Taveras N; Wang P; Fontaine RN; Salvati EA
Clin Orthop Relat Res; 2009 Jul; 467(7):1773-80. PubMed ID: 19034590
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.
Anderson DR; Wilson SJ; Blundell J; Petrie D; Leighton R; Stanish W; Alexander D; Robinson KS; Burton E; Gross M
J Bone Joint Surg Am; 2002 Nov; 84(11):1992-7. PubMed ID: 12429760
[TBL] [Abstract][Full Text] [Related]
14. A safe, effective, and easy to use warfarin initiation dosing nomogram for post-joint arthroplasty patients.
Pendleton RC; Wheeler M; Wanner N; Strong MB; Vinik R; Peters CL
J Arthroplasty; 2010 Jan; 25(1):121-7. PubMed ID: 19062248
[TBL] [Abstract][Full Text] [Related]
15. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
Enyart JJ; Jones RJ
Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Versus Postoperative Initiation of Warfarin Therapy in Patients Undergoing Total Hip and Knee Arthroplasty.
Cipriano C; Erdle N; Li K; Curtin B
Orthop Clin North Am; 2017 Jan; 48(1):9-13. PubMed ID: 27886686
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of warfarin dosing from a nomogram compared with house staff dosing.
Asnis PD; Gardner MJ; Ranawat A; Leitzes AH; Peterson MG; Bass AR
J Arthroplasty; 2007 Feb; 22(2):213-8. PubMed ID: 17275636
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
